Suppr超能文献

主要心律及传导障碍的流行病学

Epidemiology of major heart rhythm and conduction disorders.

作者信息

Gabet Amélie, Lailler Grégory, Fauchier Laurent, Deharo Jean-Claude, Tuppin Philippe, Leclercq Christophe, Amara Walid, Grave Clémence, Blacher Jacques, Olié Valérie

机构信息

Cardiovascular and Neurovascular Disease Surveillance Unit, Santé Publique France, 94410 Saint-Maurice, France.

Cardiovascular and Neurovascular Disease Surveillance Unit, Santé Publique France, 94410 Saint-Maurice, France.

出版信息

Arch Cardiovasc Dis. 2024 Dec;117(12):693-704. doi: 10.1016/j.acvd.2024.10.003. Epub 2024 Oct 28.

Abstract

BACKGROUND

Heart rhythm and conduction disorders cover a variety of pathologies, ranging from the benign to the immediately life threatening.

AIMS

To describe the epidemiology of patients hospitalized for arrhythmias in France, and to estimate the prevalence and mortality associated with these disorders, divided into three separate groups: atrial fibrillation and flutter; conduction disorders; and ventricular tachycardia/cardiac arrest.

METHODS

We looked in the National Health Data System and selected patients who had been hospitalized at least once in 2022 for these diseases and patients who died as a result of these diseases in 2021. The prevalence of these disorders among people alive on 1st January 2023 was estimated by combining previous hospitalizations and people in receipt of 100% coverage for a registered long-term disease.

RESULTS

At 1st January 2023, the prevalence of patients who had been hospitalized with major rhythm and conduction disorders was 2,740,141: 2,027,900 with atrial fibrillation/flutter; 999,692 with conduction disorders; and 214,989 with ventricular tachycardia/cardiac arrest. In 2022, respectively 90,502, 48,268 and 16,930 were hospitalized for these conditions, which equate to rates of 169.5, 68.3, and 31.7 per 100,000 inhabitants, respectively. Several departments in the Hauts-de-France and Grand-Est regions had rates>20% above the national rate. The rate of ventricular tachycardia/cardiac arrest was 40% higher among residents of the most deprived municipalities than among residents of the least deprived municipalities. Mortality at the end of hospitalization reached 44% for patients hospitalized for ventricular tachycardia/cardiac arrest.

CONCLUSIONS

Arrhythmias and conduction disorders affect a significant proportion of the population, leading to a large number of hospitalizations and procedures, particularly ablation techniques and pacemaker/defibrillator implantation. Given the extent of regional disparities and the impact of the socioeconomic status of the municipality of residence, targeted prevention and screening strategies should be implemented.

摘要

背景

心律和传导障碍涵盖了从良性到危及生命的各种病症。

目的

描述法国因心律失常住院患者的流行病学情况,并估计与这些病症相关的患病率和死亡率,这些病症分为三个独立的组:心房颤动和心房扑动;传导障碍;室性心动过速/心脏骤停。

方法

我们在国家卫生数据系统中进行查找,选择了2022年因这些疾病至少住院一次的患者以及2021年因这些疾病死亡的患者。通过结合既往住院情况和患有已登记长期疾病且享受100%医保覆盖的人群,估算了2023年1月1日存活人群中这些病症的患病率。

结果

2023年1月1日,因主要心律和传导障碍住院的患者患病率为2,740,141例:心房颤动/心房扑动患者2,027,900例;传导障碍患者999,692例;室性心动过速/心脏骤停患者214,989例。2022年,因这些病症住院的患者分别为90,502例、48,268例和16,930例,分别相当于每10万居民中有169.5例、68.3例和31.7例。上法兰西大区和大东部大区的几个部门的发病率比全国发病率高出20%以上。最贫困市镇居民的室性心动过速/心脏骤停发病率比最不贫困市镇居民高出40%。因室性心动过速/心脏骤停住院的患者住院末期死亡率达到44%。

结论

心律失常和传导障碍影响着相当一部分人群,导致大量住院和手术,尤其是消融技术以及起搏器/除颤器植入。鉴于地区差异程度以及居住市镇社会经济地位的影响,应实施有针对性的预防和筛查策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验